At Springboard we work hard to help people achieve their aims. This applies particularly to our clients and our staff.
One of our directors, Dr. Keith Turner, explained how and why we do this in an interview to Entrepreneur-In-Residence Dr. Soraya Jones.
Read the full interview to find out more.
Springboard recently sponsored Science Day at Fen Drayton Primary School near Cambridge. The whole school devoted the entire day to exploring numerous aspects of physics, chemistry and biology through a series of hands-on experiments. Among the many subjects were:
- What is blood made of?
- What causes clouds?
- How can you make crazy putty?
- How do rockets work?
- What are molecules made of?
The Head Teacher, Mrs Claire Turner, said that the company’s support raised the importance of science in the children’s minds because they could see that a real engineering-science company was interested in their learning. In addition, it helped to buy safety glasses and supplies for the day.
“Some of the children will likely work in the Cambridge science industry one day, and the day was a good way to ignite their enthusiasm”, she said.
Springboard’s ethos includes a strong element of mentoring and developing staff in their continuous learning, and so reaching out to primary school children is a way of starting that process right at an early stage.
But the final word on the matter goes to the children who wrote thank you letters to the company.
“It was great fun.” Ellie
“What I enjoyed was every single bit. And what I learnt was that science is so FUN!” Connor
“I learnt that some times some stuff don’t work.” Lilly-Rose
“Well, you made science day be the best day of my life.” Rhys
Tom Oakley, Director of Drug Delivery Device Development at Springboard, recently presented at the Management Forum Congress in London on ‘How devices can grow pharma profits‘.
The key challenges facing pharma were discussed, along with real-world examples of how devices can grow pharma profits by:
- Increasing drug value
- Giving extended patent protection to drugs
- Increasing the barrier to entry for generics and biosimilars
- Using existing drugs for new indications
- Increasing usability or addressing different user groups
- Changing the pharma company from a drug manufacturer to an integrated healthcare provider
Please contact Tom Oakley on +44 (0) 1223 422 273 if you represent a pharmaceutical or medical device company. We would be happy to run through the presentation with you.